Activation of valvular interstitial cells is mediated by transforming growth factor-β1 interactions with matrix molecules

Abramoff, 2004, Image processing with ImageJ, Biophoton. Int., 11, 36

Baroni, 2000, Heparin treatment reduces glomerular injury in rats with adriamycin-induced nephropathy but does not modify tubulointerstitial damage or the renal production of transforming growth factor-beta, Nephron, 84, 248, 10.1159/000045585

Blobe, 2000, Role of transforming growth factor {beta} in human disease, N. Engl. J. Med., 342, 1350, 10.1056/NEJM200005043421807

Boudreau, 1999, Extracellular matrix and integrin signalling: the shape of things to come, Biochem. J., 339, 481, 10.1042/0264-6021:3390481

Capila, 2002, Heparin–protein interactions, Angew. Chem. Int. Ed. Engl., 41, 391, 10.1002/1521-3773(20020201)41:3<390::AID-ANIE390>3.0.CO;2-B

Carroll, 2003, Heparin stimulates production of bFGF and TGF-beta 1 by human normal, keloid, and fetal dermal fibroblasts, Med. Sci. Monit., 9, BR97

Castellot, 1985, Binding and internalization of heparin by vascular smooth muscle cells, J. Cell. Physiol., 124, 13, 10.1002/jcp.1041240104

Cushing, M.C., Jaeggli, M.P., Masters, K.S., Leinwand, L.A., Anseth, K.S., (in press). “Serum Deprivation Improves Seeding and Repopulation of Acellular Matrices with Valvular Interstitial Cells.” Journal of Biomedical Materials Research, Part A.

Della Rocca, 2000, Cell composition of the human pulmonary valve: a comparative study with the aortic valve—the VESALIO* project, Ann. Thor. Surg., 70, 1594, 10.1016/S0003-4975(00)01979-2

Desmouliere, 1992, Heparin induces alpha-smooth muscle actin expression in cultured fibroblasts and in granulation tissue myofibroblasts, Lan. Invest. Dec., 67, 716

Edwards, 1987, Transforming growth-factor beta-modulates the expression of collagenase and metalloproteinase inhibitor, EMBO J., 6, 1899, 10.1002/j.1460-2075.1987.tb02449.x

Farndale, 1986, Improved quantitation and discrimination of sulfated glycosaminoglycans by use of dimethylmethylene blue, Biochim. Biophys. Acta, 883, 173, 10.1016/0304-4165(86)90306-5

Fava, 1987, Fibronectin-associated transforming growth-factor, J. Cell. Phys., 131, 184, 10.1002/jcp.1041310207

Hirst, 2000, Differential effects of extracellular matrix proteins on human airway smooth muscle cell proliferation and phenotype, Am. J. Resir. Cell Mol. Biol., 23, 335, 10.1165/ajrcmb.23.3.3990

Jian, 2003, Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis, Ann. Thorac. Surg., 75, 457, 10.1016/S0003-4975(02)04312-6

Johnson, 1987, Porcine cardiac valvular subendothelial cells in culture: cell isolation and growth characteristics, J. Mol. Cell. Cardiol., 19, 1185, 10.1016/S0022-2828(87)80529-1

Kondo, 2004, Transforming growth factor-beta1 stimulates collagen matrix remodeling through increased adhesive and contractive potential by human renal fibroblasts, Biochim. Biophys. Acta, 1693, 91, 10.1016/j.bbamcr.2004.05.005

Linhardt, 2003, 2003 Claude S. Hudson Award address in carbohydrate chemistry. Heparin: structure and activity, J. Med. Chem., 46, 2551, 10.1021/jm030176m

Lutolf, 2005, Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering, Nat. Biotechnol., 23, 47, 10.1038/nbt1055

Lyon, 1997, The interaction of the transforming growth factor-betas with heparin/heparan sulfate is isoform-specific, J. Biol. Chem., 272, 18000, 10.1074/jbc.272.29.18000

Masters, 2004, Designing scaffolds for valvular interstitial cells: cell adhesion and function on naturally derived materials, J. Biomed. Mater. Res., 71A, 172, 10.1002/jbm.a.30149

McCaffrey, 1989, Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex, J. Cell Biol., 109, 441, 10.1083/jcb.109.1.441

McCaffrey, 1992, Transforming growth factor-beta-1 is a heparin-binding protein — identification of putative heparin-binding regions and isolation of heparins with varying affinity for Tgf-Beta-1, J. Cell. Physiol., 152, 430, 10.1002/jcp.1041520226

McCaffrey, 1994, Protection of transforming growth factor-beta 1 activity by heparin and fucoidan, J. Cell. Physiol., 159, 51, 10.1002/jcp.1041590108

Messier, 1994, Dual structural and functional phenotypes of the porcine aortic valve interstitial population: characteristics of the leaflet myofibroblast, J. Surg. Res., 57, 1, 10.1006/jsre.1994.1102

Ohuchi, 2002, Assay-based quantitative analysis of PC12 cell differentiation, J. Neurosci. Methods, 118, 1, 10.1016/S0165-0270(02)00116-4

Pankov, 2002, Fibronectin at a glance, J. Cell Sci., 115, 3861, 10.1242/jcs.00059

Papetti, 2003, FGF-2 antagonizes the TGF-beta1-mediated induction of pericyte alpha-smooth muscle actin expression: a role for myf-5 and Smad-mediated signaling pathways, Invest. Ophthalmol. Vis. Sci., 44, 4994, 10.1167/iovs.03-0291

Rabkin-Aikawa, 2004, Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves, J. Heart Valve Dis., 13, 841

Saltzman, 1999, Delivering tissue regeneration, Nat. Biotechnol., 17, 534, 10.1038/9835

Savage, 2001, Antibodies against a putative heparin receptor slow cell proliferation and decrease MAPK activation in vascular smooth muscle cells, J. Cell. Physiol., 187, 283, 10.1002/jcp.1076

Schmittgraff, 1994, Heterogeneity of myofibroblast phenotypic features — an example of fibroblastic cell plasticity, Virchows Arch.—an Int. J. Pathol., 425, 3

Serini, 1998, The fibronectin domain ed-a is crucial for myofibroblastic phenotype induction by transforming growth factor-beta 1, J. Cell Biol., 142, 873, 10.1083/jcb.142.3.873

Stegemann, 2003, Altered response of vascular smooth muscle cells to exogenous biochemical stimulation in two-and three-dimensional culture, Exp. Cell Res., 283, 146, 10.1016/S0014-4827(02)00041-1

Taipale, 1997, Growth factors in the extracellular matrix, FASEB J., 11, 51, 10.1096/fasebj.11.1.9034166

Taipale, 1996, Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils, J. Histochem. Cytochem., 44, 875, 10.1177/44.8.8756760

Taylor, 2000, Phenotypic and functional characterization of interstitial cells from human heart valves, pericardium and skin, J. Heart Valve Dis., 9, 150

Tomasek, 2002, Myofibroblasts and mechano-regulation of connective tissue remodelling, Nat. Rev., Mol. Cell Biol., 3, 349, 10.1038/nrm809

Walker, 2004, Valvular myofibroblast activation by transforming growth factor-B, Circ. Res., 95, 253, 10.1161/01.RES.0000136520.07995.aa

Weigert, 2001, Low-molecular-weight heparin prevents high glucose- and phorbol ester-induced TGF-beta 1 gene activation, Kidney Int., 60, 935, 10.1046/j.1523-1755.2001.060003935.x

Yamamoto, 1993, Type-I collagen promotes modulation of cultured rabbit arterial smooth-muscle cells from a contractile to a synthetic phenotype, Exp. Cell Res., 204, 121, 10.1006/excr.1993.1016